Dr. Gautam Moorjani, MD
What this data tells you about Dr. Moorjani
Dr. Gautam Moorjani is a hospitalist physician in San Antonio, TX, with 19 years in practice. Based on federal Medicare data, Dr. Moorjani performed 168,893 Medicare services across 3,606 unique beneficiaries.
Between the years covered by Open Payments, Dr. Moorjani received a total of $19,222 from 53 pharmaceutical and/or device companies across 915 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hospitalist physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Moorjani is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Golimumab infusion (Simponi Aria) | 39,406 | $10 | $48 |
| Certolizumab injection (Cimzia) | 38,800 | $4 | $19 |
| Abatacept infusion (Orencia) | 30,300 | $33 | $134 |
| Tocilizumab injection (Actemra) | 27,521 | $4 | $17 |
| Romosozumab injection (Evenity) for osteoporosis | 10,290 | $8 | $28 |
| Denosumab injection (Prolia/Xgeva) | 8,460 | $18 | $42 |
| Infliximab infusion (Remicade) | 3,781 | $22 | $114 |
| Injection, infliximab-abda, biosimilar, (renflexis), 10 mg | 1,570 | $29 | $119 |
| Extended-release steroid injection (Zilretta) | 1,184 | $13 | $42 |
| Office visit, established patient (30-39 min) | 965 | $88 | $253 |
| Comprehensive metabolic blood panel | 923 | $10 | $26 |
| C-reactive protein test (inflammation marker) | 855 | $5 | $14 |
| Complete blood count (CBC) with differential | 833 | $8 | $20 |
| Sed rate test (inflammation marker) | 815 | $3 | $6 |
| Administration of chemotherapy into vein, 1 hour or less | 798 | $97 | $399 |
| Measurement of antibody for assessment of autoimmune disorder, any method | 436 | $17 | $44 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 419 | $56 | $222 |
| Measurement of complement (immune system proteins), antigen, | 164 | $11 | $29 |
| Analysis of substance using immunoassay technique, multiple step method | 138 | $11 | $28 |
| Administration of chemotherapy into vein, each additional hour | 123 | $21 | $85 |
| New patient office visit (45-59 min) | 100 | $124 | $497 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 90 | $87 | $258 |
| Measurement of dna antibody, native or double stranded | 85 | $13 | $35 |
| Measurement of dna antibody, single stranded | 85 | $12 | $29 |
| Vitamin D level test | 79 | $29 | $72 |
| Uric acid level test | 73 | $4 | $12 |
| Measurement of antibody for rheumatoid arthritis assessment | 72 | $12 | $32 |
| Rheumatoid factor level | 69 | $5 | $15 |
| Injection, methylprednisolone acetate, 40 mg | 54 | $6 | $15 |
| Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | 48 | $101 | $311 |
| Creatine kinase (cardiac enzyme) level, total | 47 | $6 | $17 |
| Office visit, established patient (20-29 min) | 40 | $47 | $166 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 39 | $3 | $13 |
| Screening test for autoimmune disorder | 35 | $11 | $29 |
| Injection of additional new drug or substance into vein | 35 | $12 | $47 |
| Flu vaccine, quadrivalent | 30 | $71 | $75 |
| Flu vaccine administration | 29 | $30 | $61 |
| Drug injection, under skin or into muscle | 22 | $11 | $42 |
| Injection, methylprednisolone acetate, 80 mg | 20 | $8 | $28 |
| Injection, methylprednisolone acetate, 20 mg | 18 | $3 | $4 |
| Joint injection, major joint | 16 | $59 | $170 |
| Vitamin B-12 level test | 13 | $15 | $38 |
| Office visit, established patient, complex (40-54 min) | 13 | $115 | $331 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (86%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 1% for hospitalist physician in TX.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Moorjani is a mixed practice specialist, with above-average Medicare volume (top 0% in TX), and high industry engagement (low-engagement, top 1%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Moorjani experienced with golimumab infusion (simponi aria)?
Does Dr. Moorjani receive payments from pharmaceutical companies?
How do Dr. Moorjani's costs compare to other hospitalist physicians in San Antonio?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology